For several years we in this laboratory have been interested in the effects of obesity on the liver. Accumulations of fat have been observed in the livers of rats with insulin-induced polyphagia' and also in rats with hypothalamic polyphagia and obesity.' In both cases, the fat was present periportally rather than centrolobularly.
ad libitum. Goldthioglucose was injected intraperitoneally in a concentration of 100 mg. per ml. of sesame oil.* At the termination of each experiment, the mice were weighed and were killed by decapitation. Blocks of liver were fixed in formalin containing 100 gm. each of calcium chloride and cobaltous nitrate per liter. Sections were cut with a freezing microtome and were stained for fat with oil red 0. Blocks of livers of selected animals from Experiment II were fixed for one hour in Dalton's chrome-osmic acid fixative, washed, dehydrated in alcohol, and embedded in a solution of 1 part butyl methacrylate in 7 parts of methyl methacrylate with benzoyl peroxide added as the polymerizing agent. Polymerization was carried out at 600 C. Small central veins were located by phase microscopy, and each block was trimmed to leave only the tissue including and immediately around a central vein. After thin sections were cut using a Porter-Blum microtome, the centrolobular localization was confirmed again by phase microscopy. The thin sections were photographed with a RCA Model EMU-2B electron microscope. Blocks from the same livers were also fixed in Carnoy's solution and paraffin sections were stained for glycogen by the PAS technique using duplicate sections digested by diastase as controls.
Experiment I utilized 200 mice. One hundred sixty received one or more injections of goldthioglucose. For the 35 injected mice that survived until the termination of the experiment, the initial doses ranged from 0.43 to 1.1 mg. of goldthioglucose per gm. body weight. Animals that survived for one month without abnormal weight-gain were given a second dose of goldthioglucose, 20 mg., intraperitoneally. Five mice received a third dose, 20 mg., after one more month. Thirty-eight mice were not given goldthioglucose and served as controls. Nineteen of them survived to the termination of the experiment. The mice initially were divided into two dietary groups, with each group made up of one-half of the injected and one-half of the uninjected mice. One group received a diet marginal in lipotropic adequacy for albino rats but otherwise sufficient in all essential dietary constituents.2' The second group received a similar diet supplemented with choline chloride to a level of 0.5 per cent by weight. During the last four months, all mice received the commercial diet. At autopsy the mice showed no apparent differences attributable to the initial differences in diets.
Experiment II, in which 84 mice were used, was performed to extend the observations of Experiment I. Thirty-seven mice received a single injection of goldthioglucose when approximately three months old and weighing [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] age and weight were uninjected controls. Surviving animals were autopsied after nine weeks.
To investigate possible toxic effects of goldthioglucose or its sesame oil vehicle on the liver, two more groups of mice were used. They were similar to the others with respect to age and weight. Each member of a group of 14 received V3 mg. goldthioglucose per gm. body weight intraperitoneally weekly until the experiment was terminated after nine weeks. To explore the acute effects of goldthioglucose, each member of a group of 19 mice was killed or allowed to die spontaneously within four days after intraperitoneal injection of goldthioglucose. Ten received 1 mg. per gm. of body weight, and 9 received 2 mg. per gm.
The heaviest uninjected mouse in Experiment I weighed 42 gm., and all mice that weighed 45 gm. or more were arbitrarily designated obese. The short duration of Experiment II did not permit maximum differences in body weight between obese and nonobese animals to develop; consequently obesity was defined in terms of weightgain (10 gm. or more) rather than in terms of final body weight. No uninjected control gained more than 7 gm.
Concentrations of stainable hepatic lipid were estimated for periportal and centrolobular locations by a method previously reported from this laboratory.' The grading system was as follows: Grade 0-no fat recognizable at 100 x magnification. Grade .0V
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i. Obesity was limited to mice that received injections of goldthioglucose larger than 0.6 mg. per gm. of body weight. None of the mice of Experiment II that were given nine weekly injections of 0.33 mg. of goldthioglucose per gm. of body weight became obese.
The centrolobular lipid in the livers of obese mice occurred as small droplets within the cytoplasm of parenchymal cells. The droplets usually remained small and failed to coalesce even in very fatty cells (Figs. 5 and 6 ). By light microscopy, the fat had a finely bubbly appearance instead of the homogeneous appearance characteristic of large globules. Fatty cysts were extremely rare. Fat-laden hepatic parenchymal cells of obese mice maintained their polygonal outlines, and their nuclei were usually centrally located. The fat-laden cells were enlarged, but not distorted by their content of lipid.
By electron microscopy thin septa could be seen separating the small globules of fat (Fig. 9) . These septa consisted of cytoplasm in which ergastoplasmic membranes or other organelles could not be identified. The fat was not consistently related to mitochondria. Most of it had been lost during the preparation of the tissue, but fat-containing vacuoles usually retained small amounts of osmophilic material.
Mitochondria of the centrolobular parenchymal cells of obese, fatty livers were in no way different from those of nonobese, nonfatty livers of injected or noninjected animals ( Figs. 11 and 12 ). Not only were changes in mitochondria not demonstrable among different animals, but also when mitochondria of fatty and nonfatty cells in the same animal were compared no differences were found.
The amount and distribution of stainable lipid in livers of the mice that received multiple doses of goldthioglucose to a total of 3 mg. per gm. of body weight and in the livers of nonobese mice that received single injections were similar. Small amounts of centrolobular lipid were observed in most livers, and the fat was contained in small vacuoles in parenchymal cytoplasm (Figs. 2 and 3) .
In Experiment II, the amount of centrolobular lipid in livers of nonobese, injected mice and multiple-injected mice was significantly in excess of the amount in livers of the noninjected mice (P<0.01 for both comparisons). A few of the noninjected mice showed very small amounts of hepatic lipid, but most were completely devoid of it (Fig. 4) . In Experiment I, livers of 12 of the nonobese, injected mice contained no stainable lipid, and in Experiment II, three of the nonobese, injected mice, including two that received multiple injections, showed no stainable hepatic lipid. The difference in amount of centrolobular lipid between the two nonobese groups of Experiment I is not significant.
In the experiment designed to test the acute effects of goldthioglucose, the mice that were given 1.0 mg. per gm. of body weight all survived until they were killed two or four days after injection. No stainable lipid was observed in their livers. Nine of the mice had lost weight during the period after injection, and one showed no change in weight.
Five of the mice receiving 2.0 mg. of goldthioglucose per gm. body weight died within 24 hours after injection, and 2 more were killed at that time because they were moribund. The livers of these animals contained variable amounts of stainable lipid, but it was always located periportally rather than centrolobularly. The 2 remaining mice were killed four days after injection, and neither showed any stainable hepatic lipid. Thus of the 19 mice observed for acute effects of large doses of goldthioglucose on the liver, only those that died or were killed when moribund showed any fatty change, and the lipid that did occur was chiefly periportal.
Yellow pigment was present consistently in Kupffer cells of the mice that had received goldthioglucose (Fig. 8) . It was not seen in uninjected animals. In general, the amount of pigment was proportional to the dose of goldthioglucose. The greatest quantities were found in livers of the mice that had received 3 mg. per gm. body weight. The pigment gave a positive reaction when stained by the stannous chloride method for gold" (Fig. 7) . It did not contain stainable iron. It was insoluble in alcohol and xylol, PAS-negative, and oil red 0 failed to stain it in sections cut from tissue embedded in paraffin. These observations indicate that the pigment contains gold, and that it is free of ceroid and hemosiderin. Trace amounts of ceroid were found in Kiipffer cells in all experimental groups and in controls without significant variation among groups.
The gold-containing pigment was distributed evenly throughout the hepatic lobule in contrast to the pericentral localization of fat. In electron micrographs it was extremely dense, and some deposits had crystalloid patterns (Fig. 10) .
The PAS-stained sections showed no significant variations of hepatic glycogen content or its lobular distribution among the different groups in Experiment II. Most livers contained abundant glycogen. Livers of the mice killed acutely were not stained for glycogen.
In both Experiment I and Experiment II, the livers of obese animals were heavier than the livers of nonobese animals. The differences are significant at the P<0.001 level in Experiment I.
In Experiment II, the difference between the mean weights of the livers of the obese and the once-injected, nonobese mice are significant at the P<O.OO1 level, and the differences between the obese and the uninjected, nonobese are significant at the P<O.O1 level. The differences between the hepatic weights of the obese mice and the multiple injected, nonobese mice are also significant at the P<O.O1 level. In neither experiment did the weights of the livers of the nonobese groups differ significantly.
DISCUSSION
The observation originally made by Brecher and Waxler that abnormal amounts of lipid accumulate centrolobularly in the livers of goldthioglucoseobese mice is confirmed. The data suggest that obesity, rather than a toxic effect of goldthioglucose or its sesame oil vehicle, is responsible for most of the fatty change.
Although increases in centrolobular stainable lipid occurred in some nonobese, injected mice relative to the noninjected controls, the degree of fatty change was not proportional to the dose of goldthioglucose given either as single or multiple injections. Mice killed or dying acutely following injection of goldthioglucose did not show increased centrolobular stainable lipid. These observations suggest that the minimal centrolobular fatty changes in livers of nonobese, injected mice may not have been due to an hepatotoxic effect of the goldthioglucose. It is possible that the arbitrary criteria based on body weight, or weight gain, failed to detect all of the obese mice with the result that a few animals in the nonobese, injected groups might actually have been slightly polyphagic and obese. Further evidence against a postulate that the hepatic fatty change might represent a toxic effect of goldthioglucose is the lack of any consistent juxtaposition of the sites of deposition of the stainable gold and the lipid. Gold was found only within Kupffer cells and was distributed randomly throughout the hepatic lobule. Lipid occurred in parenchymal cells and was concentrated centrolobularly. The data do not, however, definitely exclude an hepatotoxic effect of the goldthioglucose as a cause of a portion of the hepatic fatty change. If an idiosyncratic type of toxicity were operating, the effects on the liver would not necessarily be proportional to the dose of goldthioglucose.
With the exception of lobular distribution, the fatty change in the livers of goldthioglucose-obese mice resembled that in insulin-polyphagic rats and in rats made polyphagic and obese by hypothalamic electrocoagulation. In all cases lipid was deposited in the cytoplasm of parenchymal cells as small, discrete droplets. The droplets showed little tendency to coalesce, even in very fatty cells, and fatty cysts as seen in choline deficiency"' were absent or FIGs. 1-4. Representative livers of mice from Experiment II. In each of the figures. the structure nearest the center of the plate is a portal area (P) and the structure farthest from the center is a central vein (C). Lipid appears black. Frozen sections, oil red 0, hematoxylin, and light green (x140). rare. Fibrosis, necrosis, and disturbance of the lobular architectural pattern were absent. Intranuclear droplets of stainable lipid occurred in scattered cells in each condition.
The single feature that distinguished the fatty accumulation in livers of goldthioglucose-obese mice from that in insulin-treated' or hypothalamicobese rats' was the lobular distribution of the excess lipid. In the rats, the fatty change was always preponderant in the periportal areas. An explanation for the difference is not apparent. One hypothesis that might be considered is that the hepatic lobules of rats and mice have different localizations of certain enzymatic or circulatory factors. A second possibility is that the difference in distribution of fat is a result of dietary factors. In cholinedeficient mice, the type of dietary fat has been reported to influence the lobular localization of hepatic lipid.' The hypothalamic and insulin-treated rats received more saturated fat than the goldthioglucose-injected mice, but both received approximately the same dietary concentration of unsaturated fat. Neither diet was deficient in any known essential nutrient. With the exception that the rats received approximately 10 per cent more fat than the mice, distribution of calories among protein, fat, and carbohydrate, and the content of salts and fiber were similar. A third possibility is that the goldthioglucose, through a toxic effect, influenced the lobular site of deposition of lipid accumulating under the influence of polyphagia and obesity.
Choline deficiency under certain circumstances produces centrolobular fatty change in the livers of mice,""' but we do not believe that the fat accumulation in the livers of goldthioglucose-obese mice is related to choline. No evidence of choline deficiency was present in controls, and the contents of protein, methionine, and choline were much higher than in diets used to produce choline deficiency. Hyperalimentation in rats did not raise the per cent dietary requirement of choline."
Lesions in the ventromedial hypothalamic nuclei have been demonstrated consistently in goldthioglucose-obese mice. The lesions consist of edema, hemorrhage, and necrosis with loss of neurons and subsequent gliosis.6' Since destruction of the ventromedial hypothalamic nuclei of mice' and of rats8 by stereotaxic electrocoagulation also produces polyphagia and obesity, it seems well established that the effect of goldthioglucose on food intake and body weight is a result of total or partial destruction of appetite-inhibiting centers in the hypothalamus. Physiologically and biochemically, goldthioglucose-obese mice closely resemble hypothalamic-obese rats5""' in that their obesity is "regulatory" (increased caloric intake)""'""' rather than "metabolic" (increased basal rate of lipogenesis) as in certain other forms of obesity.1"'l' " " 2178 n It is evident that at the present the difference in hepatic reaction to polyphagia and obesity in goldthioglucose-obese mice and hypothalamic-obese rats cannot be attributed to differences in the metabolism of the two forms of obesity.
The dissimilarity in lobular position of lipid in livers of hypothalamicobese rats and goldthioglucose-mice may be a result of a species difference in lobular localization of function, but the other possible explanations that have been discussed cannot be discarded at the present time. The evidence in favor of a species difference appears strong enough to necessitate more extensive investigation before observations of hepatic effects of obesity in one species can be generalized to other species.
SUMMARY
Obesity following injection of goldthioglucose in mice is associated with centrolobular deposition of lipid in their livers and hepatomegaly. The lipid is deposited in parenchymal cells chiefly as small cytoplasmic droplets that bear no consistent relationship to mitochondria, ergastoplasm, or other organelles. Occasional nuclei also contain lipid. Neither the deposition of fat in the livers nor the hepatomegaly can be accounted for entirely on the basis of a direct (toxic) action of goldthioglucose; therefore, they appear attributable at least in part to the effects of polyphagia and obesity.
Hypothalamic polyphagia and obesity in rats are known to result in accumulation of hepatic fat in periportal location. The dissimilarity in the lobular site of lipid in the livers of goldthioglucose-obese mice and hypothalamic-obese rats may represent a species difference, or it may be a result of differences in the experimental treatment of the rats and the mice.
